Farnesyltransferase, CAAX Box, alpha (FNTA) (N-Term) Peptid
FNTA
Reaktivität: Human
Wirt: Synthetic
BP, WB
Produktnummer ABIN976961
150,78 €
Zzgl. Versandkosten 20,00 € und MwSt
100 μg
Lieferung nach:
Deutschland
Lieferung in 15 bis 22 Werktagen
Kurzübersicht für Farnesyltransferase, CAAX Box, alpha (FNTA) (N-Term) Peptid (ABIN976961)
Target
FNTA
(Farnesyltransferase, CAAX Box, alpha (FNTA))
Spezies
Human
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- N-Term
-
Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-FNTA antibody (Catalog #: ARP48520_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Aufreinigung
- Purified
-
-
-
-
Applikationshinweise
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Konzentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handhabung
- Avoid repeated freeze-thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- FNTA (Farnesyltransferase, CAAX Box, alpha (FNTA))
-
Hintergrund
-
Prenyltransferases attach either a farnesyl group or a geranylgeranyl group in thioether linkage to the cysteine residue of protein's with a C-terminal CAAX box. CAAX geranylgeranyltransferase and CAAX farnesyltransferase are heterodimers that share the s
Alias Symbols: FPTA, MGC99680, PGGT1A, PTAR2
Protein Interaction Partner: ACVR1,CENPF,FNTB,GBP1,HRAS,KRAS,PTP4A3,RHOB,TGFB1,TGFBR1,ACVR1,PTP4A2,TGFB1,TGFBR1
Protein Size: 312 -
Molekulargewicht
- 36 kDa
-
Gen-ID
- 2339
-
NCBI Accession
- NM_001018677, NP_001018197
Target
-
Sie sind hier:
